Change - Announcement of Cessation::Resignation of Independent Non-Executive Director

Issuer & Securities

Issuer/ Manager
PHARMESIS INTERNATIONAL LTD.
Securities
PHARMESIS INTERNATIONAL LTD. - SG1BH6000003 - BFK
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
29-Sep-2023 19:46:31
Status
New
Announcement Sub Title
Resignation of Independent Non-Executive Director
Announcement Reference
SG230929OTHRGWDA
Submitted By (Co./ Ind. Name)
Wu Xuedan
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Resignation of Chay Kwok Kee as Independent Non-Executive Director

Additional Details

Name Of Person
Chay Kwok Kee
Age
70
Is effective date of cessation known?
Yes
If yes, please provide the date
30/09/2023
Detailed Reason (s) for cessation
Mr Chay Kwok Kee has tendered his resignation as an Independent Non-Executive Director of the Company due to his health, whereby he is acting upon medical advice to reduce his workload and other principal commitments so as to recuperate and recover his health.

The Board and Management of the Company would like to express their gratitude to Mr Chay Kwok Kee for his invaluable contributions during his tenure of service.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
27/04/2018
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
1
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
2
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Non-Executive Director and a member of Audit Committee, Nominating Committee and Remuneration Committee
Role and responsibilities
The role and responsibilities as an Independent Non-Executive Director and a member of Audit Committee, Nominating Committee and Remuneration Committee
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
None
Present
None